May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Relationship Between Improvement of Pattern Electroretinogram Amplitude and Reduction of Intraocular Pressure in Glaucoma
Author Affiliations & Notes
  • L.M. Ventura
    Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL
  • V. Porciatti
    Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL
  • N.M. Sorokac
    Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL
  • P.F. Palmberg
    Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL
  • Footnotes
    Commercial Relationships  L.M. Ventura, None; V. Porciatti, Lace Elettronica, Pisa, Italy F; N.M. Sorokac, None; P.F. Palmberg, None.
  • Footnotes
    Support  NIH RO1 EY014957, The Glaucoma Foundation, Research to Prevent Blindness, NIH P30–EY014801
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 3776. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L.M. Ventura, V. Porciatti, N.M. Sorokac, P.F. Palmberg; Relationship Between Improvement of Pattern Electroretinogram Amplitude and Reduction of Intraocular Pressure in Glaucoma . Invest. Ophthalmol. Vis. Sci. 2005;46(13):3776.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the relationship between improvement of retinal ganglion cell (RGC) function and reduction of intraocular pressure (IOP) in glaucoma. Methods: RGC function has been evaluated by means of the pattern electroretinogram (PERG) in response to high–contrast gratings alternating at 16 Hz. The PERG has been recorded simultaneously from both eyes of 4 patients at different stages of glaucoma with elevated IOP (average initial value = 41 ± 18 mm Hg). PERG and IOP were measured before and at different intervals after IOP reduction with topical treatment. Results: Decreasing the IOP resulted in a marked improvement of PERG amplitude in all but one treated eye (median 100.9%, quartiles 32%, 166%). The improvement was relatively stable with time. The eye that did not show PERG improvement had an advanced glaucomatous visual field loss. In all eyes, IOP reduction was maximal the day after the initiation of treatment. The maximal improvement of PERG amplitude, however, was delayed, compared to the time course of IOP reduction, in 75% of eyes. The relationship between PERG amplitude and IOP was non–linear, and was well described by a power function with a median exponent of –0.445 (quartiles –0.42 –0.52). That is, the amount of PERG amplitude improvement per unit of IOP reduction was relatively greater below 21 mm Hg than above 21 mm Hg. Conclusions: The improvement in PERG amplitude after IOP lowering suggests that a population of viable RGCs is dysfunctional due to elevated IOP. Reducing IOP results in a relatively stable improvement of RGC function. Our data suggest that the PERG may be useful to establish that target IOP where RGC function is maximally improved.

Keywords: ganglion cells • intraocular pressure • electroretinography: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×